Petejova Nadezda, Martinek Arnost
Department of Internal Medicine, University Hospital Ostrava, Czech Republic.
Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):183-94. doi: 10.5507/bp.2015.050. Epub 2015 Nov 3.
The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. Early diagnosis and successful urological procedures with partial or total nephrectomy can be life-saving. However, only up to 10% of RCC patients present with characteristic clinical symptoms. Over 60% are detected incidentally in routine ultrasound examination. The question of screening and preventive measures greatly depends on the cause of the tumor development. For the latter reason, this review focuses on etiology, pathophysiology and risk factors for renal neoplasm.
A literature search using the databases Medscape, Pubmed, UpToDate and EBSCO from 1945 to 2015.
Genetic predisposition/hereditary disorders, obesity, smoking, various nephrotoxic industrial chemicals, drugs and natural/manmade radioactivity all contribute and enviromental risks are a serious concern in terms of prevention and the need to screen populations at risk. Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a knowledge of molecular pathways.
全球肾癌发病率逐年上升,其病因是多方面的。早期诊断以及通过部分或全肾切除术进行成功的泌尿外科手术可挽救生命。然而,只有高达10%的肾癌患者表现出典型临床症状。超过60%是在常规超声检查中偶然发现的。筛查和预防措施问题在很大程度上取决于肿瘤发生的原因。基于这个原因,本综述聚焦于肾肿瘤的病因、病理生理学和危险因素。
使用Medscape、Pubmed、UpToDate和EBSCO数据库对1945年至2015年的文献进行检索。
遗传易感性/遗传性疾病、肥胖、吸烟、各种肾毒性工业化学品、药物以及天然/人工放射性均有影响,就预防以及对高危人群进行筛查的必要性而言,环境风险是一个严重问题。关于治疗,目前的肿瘤学研究基于对分子途径的了解,致力于阻断癌细胞分裂并抑制血管生成。